B. Haug

Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma

B. H. Haug, J. Buechner, J. Henriksen, 2011, British Journal of Cancer.

MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.

B. H. Haug, D. Geerts, J. Buechner, 2011, Carcinogenesis.

MYCN-regulated miRNAs Inhibit Secretion of the Tumor Suppressor DICKKOPF-3 ( DKK 3 ) in Neuroblastoma Running Title : Dickkopf-3 Regulating miRNAs in Neuroblastoma

B. H. Haug, J. Buechner, B. Sveinbjørnsson, 2011 .

Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma

B. H. Haug, J. Buechner, T. Flaegstad, 2011, BMC Developmental Biology.

Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma

B. H. Haug, H. Lagercrantz, P. Papachristou, 2016, BMC Cancer.

Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.

B. H. Haug, J. Buechner, T. Flaegstad, 2011, Differentiation; research in biological diversity.

Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs.

B. H. Haug, T. Flægstad, C. Einvik, 2015, Anticancer research.